INTRODUCTION NOVORAPID PENFILL CARTRIDGE contains Insulin Aspart which belongs to the group of medicines called Antidiabetic agents. It is used to treat diabetes mellitus (both type I and type II).
Diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood. It is caused either due to inadequate production of a hormone called insulin (produced by the pancreas to metabolize glucose) in the body or due to inadequate sensitivity of body cells to the actions of insulin.
NOVORAPID PENFILL CARTRIDGE is a fast-acting medicine where it begins to lower blood sugar levels within 10-20 minutes after administration and its effects may last up to 3-4 hours. NOVORAPID PENFILL CARTRIDGE is suitable for use both in adults and in children (aged 1 year or older).
Talk to your doctor before starting therapy with NOVORAPID PENFILL CARTRIDGE if you have any liver, kidney or heart problems. You must also inform your doctor if you have any hormonal problems, made sudden changes to your diet or perform the intense exercise as a precaution.
Do not use this medicine if you have hypoglycemia (low blood sugar levels). Consult your doctor before using this medicine if you are pregnant or breastfeeding.
The most common side effects of injecting NOVORAPID PENFILL CARTRIDGE are low blood sugar levels, pain, redness, itching, swelling or thickening at the injection site, lump formation under the skin and swelling of body parts. Consult your doctor if any of these side effects troubles you.
USES OF NOVORAPID PENFILL CARTRIDGE Treats diabetes mellitus (both type I and type II) HOW NOVORAPID PENFILL CARTRIDGE WORKS NOVORAPID PENFILL CARTRIDGE helps your body to make utilize of the circulating blood glucose. It helps in the transport of glucose from the blood into the muscles and fat tissues. It also stops the production of glucose by the liver. As a result, it controls blood sugar levels and improve sugar control in patients with diabetes mellitus.
DIRECTIONS FOR USE Always inject this medicine into your thighs, buttocks, upper arm, or abdomen (i.e., subcutaneously). Do not administer this medicine into the vein or muscle directly. It should be administered at least 10 minutes before meals. Eat a meal or snack containing carbohydrates within 20 minutes of the injection to avoid low blood sugar.
Before administration, roll the vial/cartridge between your hands until the liquid becomes uniformly white and cloudy. While injecting, keep the needle under the skin for at least 6 seconds to make sure that the entire dose is injected.
Prior to the administration, visualize the cartridge/vial for any visible particulate matter and discolouration. Discard the needle and syringe after use and do not share your needles with others to avoid the risk of transmission of infections.
Avoid repeatedly injecting the medicine at the same site to prevent skin damage. Instead, rotate the injection site. Make sure to consult your doctor before changing the injection site as a precaution.
Consult your doctor before mixing NOVORAPID PENFILL CARTRIDGE with other insulins. Do not stop therapy with NOVORAPID PENFILL CARTRIDGE without consulting your doctor. Your doctor will decide correct dose and frequency of administration depending upon your age, body weight and health condition.
Exports To: Germany | Italy | Spain | United States Of America | Ireland
Find products similar to Novorapid 100IU Penfill Cartridge
Germany | Italy | Spain | United States Of America | Ireland
Established in the year 2012, Gleason Health Care are leading Exporter and Wholesale Trader of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Cream, etc.
